Trial Profile
A retrospective study of safety and efficacy of tigecycline as salvage therapy in patients with bone and joint infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2015
Price :
$35
*
At a glance
- Drugs Tigecycline (Primary)
- Indications Bone and joint infections
- Focus Adverse reactions; Therapeutic Use
- 12 Jan 2015 New trial record